PORTFOLIO NEWS Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society December 3, 2021 Read More » eFFECTOR Therapeutics Announces Publication of Zotatifin Preclinical Data in Frontiers in Oncology November 24, 2021 Read More » Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Meeting 2021, the Annual Meeting of the American Association for the Study of Liver Diseases November 15, 2021 Read More » Surrozen Reports Third Quarter 2021 Financial Results November 15, 2021 Read More » Nurix Therapeutics Presents Beneficial Effects of CBL-B Inhibition on Human Tumor Infiltrating Lymphocytes at SITC Conference November 12, 2021 Read More » Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors November 12, 2021 Read More » A2 Bio Provides First Preclinical Data Presentation for CEA and MSLN Programs, Including Trial Update at SITC 2021 November 12, 2021 Read More » RAPT Therapeutics Reports Third Quarter 2021 Financial Results November 10, 2021 Read More » Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates November 10, 2021 Read More » Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress November 10, 2021 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
Neurona Therapeutics to Present New Preclinical Data and Clinical Trial Plans for Lead Neural Cell Therapy Program, NRTX-1001, at the Annual Meeting of the American Epilepsy Society December 3, 2021 Read More »
eFFECTOR Therapeutics Announces Publication of Zotatifin Preclinical Data in Frontiers in Oncology November 24, 2021 Read More »
Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Meeting 2021, the Annual Meeting of the American Association for the Study of Liver Diseases November 15, 2021 Read More »
Nurix Therapeutics Presents Beneficial Effects of CBL-B Inhibition on Human Tumor Infiltrating Lymphocytes at SITC Conference November 12, 2021 Read More »
Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors November 12, 2021 Read More »
A2 Bio Provides First Preclinical Data Presentation for CEA and MSLN Programs, Including Trial Update at SITC 2021 November 12, 2021 Read More »
Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates November 10, 2021 Read More »
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress November 10, 2021 Read More »
